Related references
Note: Only part of the references are listed.Lipid Abnormalities in Persons Living With HIV Infection
David D. Waters et al.
CANADIAN JOURNAL OF CARDIOLOGY (2019)
Impact of Lopinavir/Ritonavir and Efavirenz-Based Antiretroviral Therapy on the Lipid Profile of Chinese HIV/AIDS Treatment-Naive Patients in Beijing: A Retrospective Study
Lili Dai et al.
CURRENT HIV RESEARCH (2019)
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials
Pedro Cahn et al.
LANCET (2019)
Six-Year Immunologic Recovery and Virological Suppression of HIV Patients on LPV/r-Based Second-Line Antiretroviral Treatment: A Multi-Center Real-World Cohort Study in China
Xiaojie Huang et al.
FRONTIERS IN PHARMACOLOGY (2019)
Efficacy and Tolerability of Lopinavir/Ritonavir- and Efavirenz-Based Initial Antiretroviral Therapy in HIV-1-Infected Patients in a Tertiary Care Hospital in Beijing, China
Bin Su et al.
FRONTIERS IN PHARMACOLOGY (2019)
Simplification to dual-therapy containing lamivudine and darunavir/ritonavir or atazanavir/ritonavir in HIV-infected patients on virologically suppressive antiretroviral therapy
Leonardo Calza et al.
INFECTIOUS DISEASES (2018)
HIV infection and lipids
Anjly Jain et al.
CURRENT OPINION IN CARDIOLOGY (2018)
Secular trends in opportunistic infections, cancers and mortality in patients with AIDS during the era of modern combination antiretroviral therapy
E. Sezgin et al.
HIV MEDICINE (2018)
Phylogenetic characteristics of HIV-1 among travelers entering China from Myanmar: A retrospective study
Li Zhang et al.
JOURNAL OF MEDICAL VIROLOGY (2017)
Defining total-body AIDS-virus burden with implications for curative strategies
Jacob D. Estes et al.
NATURE MEDICINE (2017)
Adverse effects of antiretroviral therapy on liver hepatocytes and endothelium in HIV patients: An ultrastructural perspective
Sarah Chwiki et al.
ULTRASTRUCTURAL PATHOLOGY (2017)
Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration
Soo-Yon Rhee et al.
EBIOMEDICINE (2017)
Outcome of Sentinel Hospital-based and CDC-based ART Service Delivery: A Prospective Open Cohort of People Living with HIV in China
Chuanyi Ning et al.
SCIENTIFIC REPORTS (2017)
Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial
Federico Pulido et al.
CLINICAL INFECTIOUS DISEASES (2017)
Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns
Francesca Falasca et al.
BMC INFECTIOUS DISEASES (2017)
Growing challenges for HIV programmes in Asia: clinic population trends, 2003-2013
Nicole L. De La Mata et al.
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV (2017)
Cost/efficacy analysis of preferred Spanish AIDS study group regimens and the dual therapy with lopinavir/ritonavir plus lamivudine for initial ART in HIV infected adults
Josep Maria Gatell Artigas et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2016)
Antiretroviral drug transporters and metabolic enzymes in human testicular tissue: potential contribution to HIV-1 sanctuary site
Yiying Huang et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
A Randomized Comparative Trial of Continued Abacavir/Lamivudine plus Efavirenz or Replacement with Efavirenz/Emtricitabine/Tenofovir DF in Hypercholesterolemic HIV-1 Infected Individuals
Graeme J. Moyle et al.
PLOS ONE (2015)
The Impact of Antiretroviral Therapy on Mortality in HIV Positive People during Tuberculosis Treatment: A Systematic Review and Meta-Analysis
Anna Odone et al.
PLOS ONE (2014)
Analysis of costs and cost-effectiveness of preferred GESIDA/National AIDS Plan regimens for initial antiretroviral therapy in human immunodeficiency virus infected adult patients in 2013
Antonio Javier Blasco et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2013)
Cell-Based Measures of Viral Persistence Are Associated With Immune Activation and Programmed Cell Death Protein 1 (PD-1)-Expressing CD4+ T cells
Hiroyu Hatano et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Long-Term Suppressive Combined Antiretroviral Treatment Does Not Normalize the Serum Level of Soluble CD14
Gema Mendez-Lagares et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Share Paper
